A team of researchers has patented a mobile device that can monitor cancer quickly, cheaply, effectively and non-invasively
Researchers at the URV’s Department of Physical and Inorganic Chemistry, led by the ICREA researcher, Ramon Álvarez Puebla, and the professor of Applied Physics, Francesc Díaz, and the Department of Clinical Oncology of the HM Torrelodones University Hospital, have patented a portable device that can detect tumour cells in blood.
The device counts the number of tumour cells in a blood sample in real time and is thus a highly effective tool for improving the monitoring, treatment and diagnosis of cancer.
Very useful for clinical use
The system has been successfully tested on patients in various stages of breast cancer and could be used to determine the presence of other tumours by analysing different antibodies in the blood sample.
Patients with cancer, particularly if it has metastasised, need to be constantly monitored during treatment to assess the progress of the disease. This is currently done using imaging techniques and biopsies which are invasive and not always possible. In contrast, the device designed by the URV researchers is highly sensitive and requires no surgery or treatment involving radiation. It is thus a highly useful clinical method because it improves patient quality of life by removing the need for the more invasive traditional procedures.
The device will be a useful tool for accurately determining a patient’s level of health because it can monitor cancer quickly, cheaply, effectively and non-invasively. Furthermore, it can assist in the early diagnosis of the disease and monitor tumours more effectively and in a manner that has a less negative effect on patients’ bodies.
Two integrated systems
The new device uses two systems in miniature: a flow system and an optical system. The first causes the blood cells to flow in alignment, while the second uses two optic fibres (a laser diode and a photodetector) to analyse the cells and count those which are cancerous and those which are not. The ratio between the two gives an understanding as to how the cancer is progressing.
The Latest on: Cancer detection
- After a late stage cancer diagnosis, Windsor mom says her son fell through the cracks of COVID-19 shutdownson December 3, 2020 at 2:05 am
Donna Gerardi says her 28-year-old son fell through the cracks of the local healthcare system when his cancer diagnosis went undetected for months and progressed to a late stage.
- Despite Cancer Diagnosis, Theo The Dog Is Living His Best Lifeon December 3, 2020 at 12:50 am
A Crystal Lake dog with terminal cancer has been staying busy in recent weeks, checking items off his bucket list.
- Despite coronavirus pandemic shutdowns, cancer doesn’t take a breakon December 2, 2020 at 11:53 pm
While a raging pandemic continues to force shutdowns and slowdowns throughout the country, another major risk to human health is not taking a sabbatical: cancer.In the early months of the pandemic, ...
- Pandemic impact raises fears of late cancer detection in Japanon December 2, 2020 at 5:27 pm
The coronavirus pandemic is taking a toll on cancer patients, as medical screenings have become less available in Japan as part of infection ･･･ ...
- Robin Roberts Talks Transcendental Meditation & Sends Message to Al Roker After Cancer Diagnosis (Exclusive)on December 2, 2020 at 4:12 pm
Before the year is over, Robin Roberts is delivering a bit of hope and meditation to people. The Good Morning America co-host has teamed up with a number of celebrities for the Meditate America free ...
- Birth defects linked to greater risk of cancer in later lifeon December 2, 2020 at 3:31 pm
People born with major birth defects face a higher risk of cancer throughout life, although the relative risk is greatest in childhood and then declines, finds a study published by The BMJ today.
- Man's COVID-19 battle leads to cancer diagnosison December 2, 2020 at 2:52 pm
A local man's battle with COVID-19 may have led to another discovery that likely saved his life. "I always tease everybody that I'm the only one that has a 'COVID Saved My Life' T-shirt," Frank Basler ...
- Clinical Challenges: Can MRI and Biomarkers Replace Biopsy for AS in Prostate Cancer?on December 2, 2020 at 11:32 am
Can active surveillance of prostate cancer be conducted without biopsies? While patients on active surveillance undergo periodic prostate-specific antigen (PSA) and tumor burden assessments, which ...
- Digital pathology: Proscia raises $23 million for cancer diagnosis tech; AdaptHealth in $2 billion dealon December 1, 2020 at 11:21 am
Proscia, a six-year-old Center City-based startup which says its cancer-finding Concentriq software is used by 3,000 pathologists and scientists, has raised another $23 million from investors led by ...
- Hologic Receives FDA Clearance for Latest Breakthrough in Early Breast Cancer Detection, Genius AI™ Detectionon December 1, 2020 at 5:05 am
Hologic, Inc., an innovative medical technology company primarily focused on improving women’ s health, today announced U.S. Food and Drug Administration clearance and commercial availability of the ...
via Google News and Bing News